The level of cleaved caspase-3 (active form) was increased in the two rectal cancer cell lines—SNU-503R80Gy (radioresistant rectal cancer) and SNU-503—following treatment with Abnoba Viscum Q® than that before the treatment (Fig. 2). The gene discussed is CASP3; the disease is rectal cancer.